Drug of the week - Clopidogrel
A patient has had an ischemic stroke and is prescribed an antiplatelet drug to help prevent another thrombotic event.
This is where clopidogrel comes in. But how does clopidogrel work?
Mechanism of action
Clopidogrel is a prodrug, so it needs to be converted into its active form in the body.
Its active metabolite irreversibly blocks the P2Y12 ADP receptor on platelets. This decreases platelet activation and, in turn, reduces platelet aggregation.
CYP2C19 is a liver enzyme that helps convert clopidogrel into its active form. Differences in the activity of this enzyme can affect how much active drug is produced and may affect how a person responds to clopidogrel.
Where is it used?
• Ischemic stroke
• Acute coronary syndromes
• After coronary procedures such as stent placement
One important point
Clopidogrel does not dissolve a blood clot that has already formed. Instead, it reduces platelet activation and aggregation, which helps prevent new thrombus formation.
Takeaway
Clopidogrel → active metabolite → P2Y12 receptor blockade → ↓ platelet activation → ↓ platelet aggregation
One last question:
Why does the antiplatelet effect of clopidogrel last for several days, even after the drug is removed from the blood?
What do you think?
MBH/AB